acf/google-ad-placement

<ul>
	<li>Johnson Controls International PLC&nbsp;JCI has&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/09/n23067466/johnson-controls-and-phylagen-sign-healthy-buildings-joint-development-agreement" style="background-image:initial; background-position:initial; background-size:initial; background-repeat:initial; background-attachment:initial; background-origin:initial; background-clip:initial; margin-top:0pt; margin-bottom:0pt; color:#4a6ee0" target="_blank">signed a joint development agreement</a>&nbsp;with&nbsp;Phylagen, a biotechnology company in microbiome optimization of indoor environments.&nbsp;</li>
	<li>The agreement includes a strategic investment in Phylagen. The financial terms of the deal were not disclosed.</li>
	<li>Through this agreement, the companies develop cutting-edge technology that leverages the science of building microbiomes to improve the future of healthy buildings.</li>
	<li>Price Action:&nbsp;JCI shares traded higher by 1.87% at $74.18 on the last check Thursday.</li>
</ul>

News

Contracts

Movers

Trading Ideas

Johnson Controls Invests In Phylagen For Technology On Microbiome Optimization - Johnson Controls Intl (NYSE:JCI)

Akanksha

Johnson Controls Intl

Briefs

Johnson Controls Invests In Phylagen For Technology On Microbiome Optimization

Johnson Controls International PLC

Latest Earnings

Stock Analysis

Stock Movers

Deals

Gainers And Losers

Equities

IPOs

Artificial Intelligence

Technology

Web Stories

Benzinga Inspire

Comments